Literature DB >> 20072815

Preferential expression and immunogenicity of HIV-1 Tat fusion protein expressed in tomato plant.

Marni E Cueno1, Yurina Hibi, Katsuo Karamatsu, Yasuhiro Yasutomi, Kenichi Imai, Antonio C Laurena, Takashi Okamoto.   

Abstract

HIV-1 Tat plays a major role in viral replication and is essential for AIDS development making it an ideal vaccine target providing that both humoral and cellular immune responses are induced. Plant-based antigen production, due to its cheaper cost, appears ideal for vaccine production. In this study, we created a plant-optimized tat and mutant (Cys30Ala/Lys41Ala) tat (mtat) gene and ligated each into a pBI121 expression vector with a stop codon and a gusA gene positioned immediately downstream. The vector construct was bombarded into tomato leaf calli and allowed to develop. We thus generated recombinant tomato plants preferentially expressing a Tat-GUS fusion protein over a Tat-only protein. In addition, plants bombarded with either tat or mtat genes showed no phenotypic difference and produced 2-4 microg Tat-GUS fusion protein per milligram soluble plant protein. Furthermore, tomato extracts intradermally inoculated into mice were found to induce a humoral and, most importantly, cellular immunity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20072815     DOI: 10.1007/s11248-009-9358-9

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  30 in total

1.  Two B cell epitopes of HIV-1 Tat protein have limited antigenic polymorphism in geographically diverse HIV-1 strains.

Authors:  G Goldstein; G Tribbick; K Manson
Journal:  Vaccine       Date:  2001-02-08       Impact factor: 3.641

2.  Establishment of a simple and quantitative immunospot assay for detecting anti-type II collagen antibody using an infrared fluorescence imaging system (IFIS).

Authors:  Shusuke Ota; Satoshi Kanazawa; Masaaki Kobayashi; Takanobu Otsuka; Takashi Okamoto
Journal:  J Immunol Methods       Date:  2005-04-07       Impact factor: 2.303

3.  Immunogenicity of a novel, bivalent, plant-based oral vaccine against hepatitis B and human immunodeficiency viruses.

Authors:  Sergei N Shchelkunov; Rurik K Salyaev; Sergei G Pozdnyakov; Natalia I Rekoslavskaya; Andrei E Nesterov; Tatiana S Ryzhova; Valentina M Sumtsova; Natalia V Pakova; Uliana O Mishutina; Tatiana V Kopytina; Rosemarie W Hammond
Journal:  Biotechnol Lett       Date:  2006-06-23       Impact factor: 2.461

Review 4.  Toward an AIDS vaccine.

Authors:  Bruce D Walker; Dennis R Burton
Journal:  Science       Date:  2008-05-09       Impact factor: 47.728

5.  Demonstration of virus-specific transcriptional activator(s) in cells infected with HTLV-III by an in vitro cell-free system.

Authors:  T Okamoto; F Wong-Staal
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

6.  Reciprocal modulation of transcriptional activities between HIV-1 Tat and MHC class II transactivator CIITA.

Authors:  H Okamoto; K Asamitsu; H Nishimura; N Kamatani; T Okamoto
Journal:  Biochem Biophys Res Commun       Date:  2000-12-20       Impact factor: 3.575

7.  Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.

Authors:  P Borrow; H Lewicki; B H Hahn; G M Shaw; M B Oldstone
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

8.  A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans.

Authors:  Matilu Mwau; Inese Cebere; Julian Sutton; Priscilla Chikoti; Nicola Winstone; Edmund G-T Wee; Tara Beattie; Yun-Hsiang Chen; Lucy Dorrell; Helen McShane; Claudia Schmidt; Mary Brooks; Sandip Patel; Joanna Roberts; Christopher Conlon; Sarah L Rowland-Jones; Job J Bwayo; Andrew J McMichael; Tomáš Hanke
Journal:  J Gen Virol       Date:  2004-04       Impact factor: 3.891

9.  Identification of a peptide capable of inducing an HIV-1 Tat-specific CTL response.

Authors:  C B Morris; A Thanawastien; D E Sullivan; J D Clements
Journal:  Vaccine       Date:  2001-10-12       Impact factor: 3.641

10.  Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial.

Authors:  Tetsuro Matano; Masahiro Kobayashi; Hiroko Igarashi; Akiko Takeda; Hiromi Nakamura; Munehide Kano; Chie Sugimoto; Kazuyasu Mori; Akihiro Iida; Takahiro Hirata; Mamoru Hasegawa; Takae Yuasa; Masaaki Miyazawa; Yumiko Takahashi; Michio Yasunami; Akinori Kimura; David H O'Connor; David I Watkins; Yoshiyuki Nagai
Journal:  J Exp Med       Date:  2004-06-21       Impact factor: 14.307

View more
  4 in total

Review 1.  Current status and perspectives of plant-based candidate vaccines against the human immunodeficiency virus (HIV).

Authors:  Sergio Rosales-Mendoza; Néstor Rubio-Infante; Dania O Govea-Alonso; Leticia Moreno-Fierros
Journal:  Plant Cell Rep       Date:  2011-12-13       Impact factor: 4.570

2.  An Env-derived multi-epitope HIV chimeric protein produced in the moss Physcomitrella patens is immunogenic in mice.

Authors:  Lucía Orellana-Escobedo; Sergio Rosales-Mendoza; Andrea Romero-Maldonado; Juliana Parsons; Eva L Decker; Elizabeth Monreal-Escalante; Leticia Moreno-Fierros; Ralf Reski
Journal:  Plant Cell Rep       Date:  2014-12-05       Impact factor: 4.570

3.  Production of pharmaceutical proteins in solanaceae food crops.

Authors:  Maria Manuela Rigano; Giorgio De Guzman; Amanda M Walmsley; Luigi Frusciante; Amalia Barone
Journal:  Int J Mol Sci       Date:  2013-01-29       Impact factor: 5.923

Review 4.  Recombinant Plant Engineering for Immunotherapeutic Production.

Authors:  Ankit Singh; Gurminder Kaur; Sanchita Singh; Neetu Singh; Gauri Saxena; Praveen C Verma
Journal:  Curr Mol Biol Rep       Date:  2017-10-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.